AngioDynamics ROA 2010-2025 | ANGO
Current and historical return on assets (ROA) values for AngioDynamics (ANGO) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
| AngioDynamics ROA - Return on Assets Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Total Assets | Return on Assets |
| 2025-02-28 | $-0.04B | $0.29B | -13.79% |
| 2024-11-30 | $-0.23B | $0.29B | -73.23% |
| 2024-08-31 | $-0.24B | $0.29B | -67.64% |
| 2024-05-31 | $-0.18B | $0.32B | -44.96% |
| 2024-02-29 | $-0.19B | $0.33B | -41.47% |
| 2023-11-30 | $-0.01B | $0.50B | -2.51% |
| 2023-08-31 | $0.01B | $0.49B | 1.50% |
| 2023-05-31 | $-0.05B | $0.53B | -9.31% |
| 2023-02-28 | $-0.04B | $0.54B | -6.51% |
| 2022-11-30 | $-0.03B | $0.56B | -5.79% |
| 2022-08-31 | $-0.03B | $0.56B | -5.80% |
| 2022-05-31 | $-0.03B | $0.55B | -4.71% |
| 2022-02-28 | $-0.04B | $0.54B | -7.05% |
| 2021-11-30 | $-0.04B | $0.55B | -6.75% |
| 2021-08-31 | $-0.03B | $0.56B | -5.94% |
| 2021-05-31 | $-0.03B | $0.56B | -5.35% |
| 2021-02-28 | $-0.17B | $0.58B | -28.78% |
| 2020-11-30 | $-0.17B | $0.59B | -27.37% |
| 2020-08-31 | $-0.17B | $0.58B | -25.81% |
| 2020-05-31 | $-0.17B | $0.59B | -24.37% |
| 2020-02-29 | $0.05B | $0.73B | 6.57% |
| 2019-11-30 | $0.06B | $0.73B | 7.40% |
| 2019-08-31 | $0.06B | $0.69B | 7.90% |
| 2019-05-31 | $0.06B | $0.84B | 8.02% |
| 2019-02-28 | $0.01B | $0.78B | 0.68% |
| 2018-11-30 | $0.02B | $0.78B | 2.50% |
| 2018-08-31 | $0.02B | $0.69B | 2.29% |
| 2018-05-31 | $0.02B | $0.71B | 2.28% |
| 2018-02-28 | $0.00B | $0.70B | 0.14% |
| 2017-11-30 | $-0.01B | $0.70B | -1.42% |
| 2017-08-31 | $0.00B | $0.70B | 0.57% |
| 2017-05-31 | $0.01B | $0.71B | 0.70% |
| 2017-02-28 | $-0.03B | $0.70B | -3.49% |
| 2016-11-30 | $-0.03B | $0.71B | -3.70% |
| 2016-08-31 | $-0.04B | $0.73B | -5.53% |
| 2016-05-31 | $-0.04B | $0.73B | -5.71% |
| 2016-02-29 | $0.00B | $0.75B | -0.13% |
| 2015-11-30 | $-0.01B | $0.76B | -0.78% |
| 2015-08-31 | $-0.01B | $0.77B | -0.64% |
| 2015-05-31 | $0.00B | $0.77B | -0.51% |
| 2015-02-28 | $-0.01B | $0.78B | -0.63% |
| 2014-11-30 | $0.00B | $0.80B | 0.50% |
| 2014-08-31 | $0.00B | $0.80B | 0.38% |
| 2014-05-31 | $0.00B | $0.80B | 0.38% |
| 2014-02-28 | $0.00B | $0.79B | 0.50% |
| 2013-11-30 | $0.00B | $0.80B | -0.25% |
| 2013-08-31 | $0.00B | $0.80B | 0.00% |
| 2013-05-31 | $0.00B | $0.79B | -0.13% |
| 2013-02-28 | $-0.01B | $0.80B | -0.93% |
| 2012-11-30 | $-0.01B | $0.78B | -1.20% |
| 2012-08-31 | $-0.01B | $0.72B | -1.37% |
| 2012-05-31 | $-0.01B | $0.72B | -1.17% |
| 2012-02-29 | $0.00B | $0.45B | 0.00% |
| 2011-11-30 | $0.01B | $0.44B | 1.37% |
| 2011-08-31 | $0.01B | $0.44B | 1.61% |
| 2011-05-31 | $0.01B | $0.44B | 1.86% |
| 2011-02-28 | $0.01B | $0.43B | 3.05% |
| 2010-11-30 | $0.01B | $0.43B | 2.85% |
| 2010-08-31 | $0.01B | $0.42B | 2.88% |
| 2010-05-31 | $0.01B | $0.42B | 2.90% |
| 2010-02-28 | $0.01B | $0.41B | 2.69% |
| 2009-11-30 | $0.01B | $0.41B | 2.46% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.411B | $0.304B |
| AngioDynamics Inc. designs, manufactures and sells a wide range of medical, surgical and diagnostic devices. The devices are generally used in minimally invasive, image-guided procedures. AngioDynamics product offerings fall within three Global Business Units, namely Oncology/Surgery, Endovascular Therapies and Vascular Access. Endovascular Therapies product offerings support the medical areas of Thrombus Management, Atherectomy, Peripheral Products and Venous Insufficiency. The Thrombus Management portfolio includes the proprietary AngioVac venous drainage cannula and circuit as well as catheter directed thrombolytic devices. Vascular Access arm offers advanced imaging equipment to guide the placement of catheters that primarily deliver short-term drug therapies. IGVA procedures include the placement of Peripherally Inserted Central Catheters lines, implantable ports and central venous catheters. Oncology/Surgery division includes Microwave Ablation, Radiofrequency Ablation and NanoKnife product lines. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $187.481B | 82.12 |
| Thermo Fisher Scientific (TMO) | United States | $152.647B | 18.46 |
| Edwards Lifesciences (EW) | United States | $44.494B | 29.17 |
| Alcon (ALC) | Switzerland | $43.016B | 29.07 |
| IDEXX Laboratories (IDXX) | United States | $42.664B | 49.03 |
| DexCom (DXCM) | United States | $34.337B | 53.07 |
| IQVIA Holdings (IQV) | United States | $27.434B | 15.37 |
| Mettler-Toledo (MTD) | United States | $24.631B | 29.29 |
| STERIS (STE) | Ireland | $23.569B | 25.96 |
| Waters (WAT) | United States | $20.638B | 29.12 |
| SONOVA HOLDING (SONVY) | Switzerland | $18.019B | 0.00 |
| Hologic (HOLX) | United States | $14.447B | 15.70 |
| Sysmex ADR (SSMXY) | Japan | $10.802B | 30.64 |
| Penumbra (PEN) | United States | $9.903B | 77.73 |
| Masimo (MASI) | United States | $9.232B | 34.05 |
| Globus Medical (GMED) | United States | $7.941B | 18.92 |
| Glaukos (GKOS) | United States | $5.725B | 0.00 |
| Teleflex (TFX) | United States | $5.307B | 8.76 |
| TransMedics (TMDX) | United States | $4.486B | 97.53 |
| Integer Holdings (ITGR) | United States | $4.202B | 22.01 |
| PROCEPT BioRobotics (PRCT) | United States | $3.261B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.510B | 14.94 |
| Veracyte (VCYT) | United States | $2.105B | 29.54 |
| Nihon Kohden (NHNKY) | Japan | $1.997B | 22.90 |
| Elekta AB (EKTAY) | Sweden | $1.910B | 17.17 |
| Alphatec Holdings (ATEC) | United States | $1.659B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.344B | 0.00 |
| Artivion (AORT) | United States | $1.328B | 124.44 |
| Pulse Biosciences (PLSE) | United States | $1.036B | 0.00 |
| OPKO Health (OPK) | United States | $1.023B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.922B | 4.91 |
| IRadimed (IRMD) | United States | $0.769B | 39.02 |
| SiBone (SIBN) | United States | $0.760B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.682B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.573B | 8.91 |
| RxSight (RXST) | United States | $0.557B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.538B | 12.61 |
| OrthoPediatrics (KIDS) | United States | $0.520B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.483B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.467B | 12.43 |
| AxoGen (AXGN) | United States | $0.462B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.430B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.372B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.360B | 0.00 |
| NeuroPace (NPCE) | United States | $0.353B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.326B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.241B | 14.61 |
| 908 Devices (MASS) | United States | $0.237B | 0.00 |
| Neuronetics (STIM) | United States | $0.233B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.227B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.220B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.209B | 0.00 |
| Inogen (INGN) | United States | $0.190B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.168B | 0.00 |
| CVRx (CVRX) | United States | $0.158B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.148B | 0.00 |
| LENSAR (LNSR) | United States | $0.147B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.145B | 0.00 |
| Accuray (ARAY) | United States | $0.135B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.129B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.107B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.104B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.089B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.077B | 47.10 |
| InspireMD (NSPR) | United States | $0.076B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.073B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.065B | 0.00 |
| Hyperfine (HYPR) | United States | $0.056B | 0.00 |
| Spectral AI (MDAI) | United States | $0.053B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.048B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.042B | 0.00 | |
| Precision Optics (POCI) | United States | $0.035B | 0.00 |
| DarioHealth (DRIO) | United States | $0.032B | 0.00 |
| Envoy Medical (COCH) | United States | $0.030B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.020B | 0.00 |
| NexGel (NXGL) | United States | $0.018B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.011B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.010B | 0.00 |
| PAVmed (PAVM) | United States | $0.010B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.008B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.007B | 0.00 |
| Tenon Medical (TNON) | United States | $0.007B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.006B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.004B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Nuwellis (NUWE) | United States | $0.001B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 15.89 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |